EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Immune Treatment Strategies in Unexplained Recurrent Pregnancy Loss

Rui Cai iD, Qiaoran Yang, Yingjun Liao, Lang Qin iD, Jinbiao Han, Rui Gao

American Journal of Reproductive Immunology · 2025

DOI: 10.1111/aji.70060 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Reproductive Immunology, 2025. Verfasst von Rui Cai und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Reproductive Medical Center, Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Abortion, Habitual, Immunotherapy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 123 Literaturangaben. Gefördert von: Sichuan Province Science and Technology Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recurrent pregnancy loss (RPL) is characterized by the occurrence of two or more consecutive pregnancy losses. Approximately half of these cases lack a clear etiology and are termed unexplained recurrent pregnancy loss (URPL). Maternal–fetal immune dysfunction is thought to be involved in causing URPL. Increased human leukocyte antigen compatibility, susceptibility genes, lack of blocking antibodies, and dysfunction of immune cells can all disrupt the immune tolerance environment of the maternal–fetal interface. To correct the maternal–fetal immune imbalances, some immunotherapies were recently tried to be used for patients with URPL. This review summarizes the characteristics and mechanisms of the immune microenvironment at the maternal–fetal interface of URPL patients, and the present immunotherapies for URPL patients, to serve as a reference for future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abortion, HabitualImmunotherapyHumansFemalePregnancyImmune ToleranceMaternal-Fetal Exchange

Stichwörter der Autor:innen

immunotherapiesmaternal–fetal immune toleranceunexplained recurrent pregnancy loss

Autor:innen und Institutionen

  • The Reproductive Medical Center, Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China.
  • Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial T…
  • Department of Outpatient, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Rui Cai, Lang Qin

Förderung

  • Sichuan Province Science and Technology Department

Zitieren

APA

Cai, R., Yang, Q., Liao, Y., Qin, L., Han, J., & Gao, R. (2025). Immune Treatment Strategies in Unexplained Recurrent Pregnancy Loss. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70060

Vancouver

Cai R, Yang Q, Liao Y, Qin L, Han J, Gao R. Immune Treatment Strategies in Unexplained Recurrent Pregnancy Loss. American Journal of Reproductive Immunology. 2025. doi:10.1111/aji.70060

BibTeX
@article{Cai2025,
  author = {Cai, Rui and Yang, Qiaoran and Liao, Yingjun and Qin, Lang and Han, Jinbiao and Gao, Rui},
  title = {Immune Treatment Strategies in Unexplained Recurrent Pregnancy Loss},
  journal = {American Journal of Reproductive Immunology},
  year = {2025},
  doi = {10.1111/aji.70060}
}
Kostenlos starten →